¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå : Á¦Ç° À¯Çüº°, Àç·áº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Nasal Cannula Market, By Product Type, By Material, By Application, By End User, By Region
»óǰÄÚµå : 1747485
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,174,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,604,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,721,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ºñ°­ ij´¼¶ó ½ÃÀåÀº 2025³â¿¡ 87¾ï 1,000¸¸ ´Þ·¯, 2032³â¿¡´Â 134¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 6.4%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 87¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 6.40% 2032³â °¡Ä¡ ¿¹Ãø 134¾ï 5,000¸¸ ´Þ·¯

ºñ°­ ij´¼¶ó ÀåÄ¡´Â õ½Ä, Æó¾Ï, Æó·Å, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), Æó¼¶À¯Áõ µî È£Èí±â Áúȯ ȯÀÚ¿¡°Ô »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ »ç¿ëµË´Ï´Ù. ÀÌ ±â±¸´Â ÇÃ¶ó½ºÆ½ ¶Ç´Â ½Ç¸®ÄÜ ÀçÁú·Î ¸¸µé¾îÁ³À¸¸ç, »ê¼Ò¸¦ °ø±ÞÇϱâ À§ÇØ Ä౸¸ÛÀ» ¿¬°áÇÏ´Â µÎ °³ÀÇ µ¹ÃâºÎ°¡ ÀÖ´Â Æ©ºêÇü ±¸Á¶·Î µÇ¾î ÀÖ½À´Ï´Ù. ÀÌ Æ©ºê´Â ±Í µÚÂÊ¿¡ ÀåÂøµÇ¾î ÇÁ·ÕÀ» ½±°Ô Á¶ÀýÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñ°­ ij´¼¶ó Æ©ºê´Â Àú·ÅÇÑ °¡°ÝÀ¸·Î ±¸ÀÔÇÒ ¼ö ÀÖ¾î ºñ°­ ij´¼¶ó ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½ÃÁß¿¡´Â ´Ù¾çÇÑ À¯ÇüÀÇ ºñ°­ ij´¼¶ó°¡ ÀÖÀ¸¸ç, ¹Ì¼÷¾Æ, È£Èí±â ÁúȯÀ» ¾Î°í ÀÖ´Â ¼ºÀÎ, Æó¾Ï ȯÀÚ, COVID-19·Î ÀÎÇÑ È£ÈíºÎÀü ȯÀÚ¿¡°Ô »ç¿ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÃÀå ÁøÃâ±â¾÷µéÀº È£Èí±â Áúȯ Ä¡·á¸¦ À§ÇÑ ¿¬±¸ °³¹ß Ȱµ¿À» °­È­Çϱâ À§ÇØ °øµ¿ ¿¬±¸¿Í °°Àº ¹«±â Ȱµ¿¿¡ ¸ôµÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È ºñ°­ ij´¼¶ó ¼¼°è ½ÃÀåÀÇ ¼ºÀåÀ» Áõ°¡½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 2¿ù 17ÀÏ Vir Biotechnology¿Í GSK´Â µ¶°¨ ¹× È£Èí±â ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ °í±Þ Ä¡·áÁ¦¸¦ °³¹ßÇϱâ À§ÇØ Äڷγª ¹ÙÀÌ·¯½º¿¡ ´ëÇÑ °øµ¿ ¿¬±¸¸¦ È®´ëÇß½À´Ï´Ù. ¹é½Å, Çõ½Å ÀǾàǰ, ÇコÄɾî Á¦Ç° Á¦Á¶¾÷üÀÎ GSK´Â ¹é½Å, Çõ½Å ÀǾàǰ, ÇコÄɾî Á¦Ç° Á¦Á¶¾÷üÀÔ´Ï´Ù. À̹ø Á¦ÈÞÀÇ ¸ñÀûÀº VirÀÇ ´ÜÀÏŬ·ÐÇ×ü ±â¼úÀ» »ç¿ëÇÏ¿© Äڷγª19 ¹× ÇâÈÄ ¹ß»ýÇÒ ¼ö ÀÖ´Â º´¿ø¼º ÁúȯÀÇ Ä¡·á ¹× ¿¹¹æÀ» À§ÇÑ µ¿ÀÏÇÑ ½Å±Ô Ç×¹ÙÀÌ·¯½º Ç×ü¸¦ Á¦ÀÛÇÏ´Â °ÍÀÔ´Ï´Ù.

È£Èí±â ÁúȯÀÇ Ä¡·á ¹× °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È ºñ°­ ij´¼¶ó ½ÃÀåÀÇ ¼¼°è ¼ºÀåÀÌ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 9¿ù 9ÀÏ¿¡ ¹ßÇ¥µÈ AstraZenecaÀÇ ´º½º¿¡ µû¸£¸é, ¼¼°è Á¦¾à ȸ»çÀÌÀÚ Çõ½ÅÀûÀÎ ÀǾàǰ Á¦Á¶¾÷üÀÎ AstraZeneca´Â COVID-19 ÀÌÈÄ ±¹°¡ È£Èí±â Àü·«ÀÇ ±ä±ÞÇÑ Çʿ伺¿¡ ´ëÇÑ ±¹Á¦ È£Èí±â ¿¬ÇÕ(International Respiratory Coalition)À̶ó´Â ÇÁ·Î±×·¥À» Ãâ¹üÇÏ¿© ÀÇ·á ½Ã½ºÅÛÀÇ È¸º¹·Â Çâ»óÀ» ÃËÁøÇß½À´Ï´Ù. À§ÇÑ ±¹Á¦ È£Èí±â ¿¬ÇÕÀ̶ó´Â ÇÁ·Î±×·¥À» ½ÃÀÛÇß½À´Ï´Ù. ÀÌ ÇÁ·Î±×·¥Àº À¯·´È£Èí±âÇÐȸ¿Í Çù·ÂÇÏ¿© È£Èí±â ÁúȯÀ» ¾Î°í Àִ ȯÀڵ鿡°Ô ÀÇ·á ½Ã¼³À» Á¦°øÇϱâ À§ÇÑ Àڱݰú Àü¹®Áö½ÄÀ» Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå - COVID-19ÀÇ ¿µÇ⠺м®

Á¦5Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå, Á¦Ç° À¯Çüº°, 2020³â-2032³â

Á¦6Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå, Àç·áº°, 2020³â-2032³â

Á¦7Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå, ¿ëµµº°, 2020³â-2032³â

Á¦8Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020³â-2032³â

Á¦9Àå ¼¼°èÀÇ ºñ°­ ij´¼¶ó ½ÃÀå, Áö¿ªº°, 2020³â-2032³â

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ¼½¼Ç

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Nasal Cannula Market is estimated to be valued at USD 8.71 Bn in 2025 and is expected to reach USD 13.45 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 8.71 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 6.40% 2032 Value Projection: USD 13.45 Bn

The nasal cannula device is used to deliver oxygen to patients with respiratory diseases such as asthma, lung cancer, pneumonia, Chronic Obstructive Pulmonary Diseases (COPD), and pulmonary fibrosis. This device is made up of plastic or silicon material and has a tube-like structure with two prongs to connect nostrils for providing oxygen. These tubes are placed behind the ear to allow for better adjustment of the prongs. These nasal cannula tubes are available at a low cost, which drives the growth of the nasal cannula market. There are different types of nasal cannulas available in the market which are used for pre-mature infants, adults suffering from respiratory diseases, patients with lung cancer, or patients with respiratory failure due to COVID-19.

Market Dynamics

Market players are indulged in inorganic activities such as collaborations in order to increase research and development activities for the treatment of respiratory diseases. This is expected to increase the growth of the global nasal cannula market over the forecast period. For instance, on February 17, 2021, Vir Biotechnology and GSK expanded their coronavirus collaboration to develop advanced therapeutics for influenza and respiratory viruses. Vir Biotechnology is immunology focused company aims for developing technologies for infectious diseases and GSK is manufacturer of vaccines, innovative medicines and healthcare products. The aim of this collaboration is to use Vir's monoclonal antibody technology to create an identical new anti-viral antibodies for therapeutic treatments and preventions for COVID -19 or future outbreaks of the pathogenic diseases.

Increasing awareness for the treatment as well as management of respiratory diseases is expected to increase the growth of the global nasal cannula market over the forecast period. For instance, a news published on September 9, 2021 by AstraZeneca is a global pharmaceutical business company and manufacturer of innovative medicines has launched program called as International Respiratory Coalition for Urgent need for national respiratory strategies after COVID-19 to drive the improvements in healthcare systems resilience. It is coordinated with European Respiratory Society .This program will provide funding or contribution with expertise for delivering facilities to patients suffering for respiratory diseases.

Key features of the study

Market Segmentation

Table of Contents

1. Research Objective and Assumption

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Nasal Cannula Market, - COVID-19 Impact Analysis

5. Global Nasal Cannula Market, By Product Type, 2020 - 2032, (US$ Bn)

6. Global Nasal Cannula Market, By Material, 2020 - 2032, (US$ Bn)

7. Global Nasal Cannula Market, By Application, 2020 - 2032, (US$ Bn)

8. Global Nasal Cannula Market, By End User, 2020 - 2032, (US$ Bn)

9. Global Nasal Cannula Market, By Region, 2020 - 2032, (US$ Bn)

10. Competitive Landscape

11. Section

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â